Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
14.79%
↑ 158% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthAccelerating
Average
-25.51%
Historical baseline
PeriodValue
202514.79%
2024-6.96%
2023-16.18%
2022-29.52%
2021-100.08%
2020-40.62%
20190.00%